📅 Next earnings: October 28, 2026
Biogen Inc. (BIIB) — Pre-Earnings Stock Analysis
Healthcare, Drug Manufacturers - General
🔥 Get BIIB Targets Before Earnings
Pre-earnings entry zone, analyst PE target, 3-day and 5-day implied move, and stop loss — all unlocked with a $5/month subscription.
Unlock Full Analysis →
About Biogen Inc. (BIIB)
Biogen Inc. trades on NASDAQ under the ticker BIIB. The company operates in the Healthcare sector — specifically Drug Manufacturers - General.
Current analyst consensus rating: Buy with a $244 price target based on 32 analyst opinions.
EPS (trailing): $5.54 | Market Cap: $33.8B
Healthcare Drug Manufacturers - General
Pre-Earnings Trading Strategy for BIIB
Trading stocks before earnings requires understanding three key variables: the implied move (what the options market expects), the historical beat rate for the sector, and the current momentum leading into the report.
For BIIB, the next earnings report is scheduled for October 28, 2026.
The implied move is calculated using at-the-money straddles — if the straddle is priced at X%, the market is pricing in approximately a ±X% move in either direction around the earnings release.
- Buy before earnings when the implied move is lower than historical actual moves — the options are cheap relative to what the stock has historically done.
- Set a stop loss at 10% below entry for pre-earnings positions — earnings volatility can swing 20-30% on a miss.
- Sell within 5 days of a beat — momentum after a positive earnings surprise typically fades within a week as short-term traders take profits.
- Check short interest — high short interest (elevated) increases squeeze potential on a beat.
How AI Market Cap Finds Pre-Earnings Setups
Our pre-earnings momentum scanner scores BIIB across five factors to identify high-conviction setups:
- Analyst conviction — Strong Buy ratings from 32 analysts driving price targets above current market price.
- Implied volatility rank — Whether options premiums are attractively priced relative to historical volatility.
- Pre-earnings momentum — Whether the stock has been trending in the direction of the expected beat.
- Sector sentiment — How the broader Healthcare sector is positioned heading into this earnings cycle.
- Days to earnings — The sweet spot is 5-12 days before — enough time for momentum to develop, not enough time for premium decay to hurt.
The Pro subscription shows the full target range, stop loss, and implied move for BIIB and all 20+ stocks in the current earnings window.